Japanese Journal of Allergology最新文献_第6页

[JAPANESE GUIDELINES FOR FOOD ALLERGY 2021]. [日本食物过敏指南 2021]。

Japanese Journal of Allergology Pub Date : 2024-01-01 DOI: 10.15036/arerugi.73.389

Yukihiro Ohya

引用次数: 0

[T FOLLICULAR HELPER CELLS AND ALLERGY]. [t滤泡辅助细胞与过敏]。

Japanese Journal of Allergology Pub Date : 2024-01-01 DOI: 10.15036/arerugi.73.231

Sari Hatanaka, Yoshitaka Honda, Hideki Ueno

引用次数: 0

[AN UPDATED REVIEW OF FOOD ALLERGY PREVENTION STRATEGIES]. [食物过敏预防策略最新回顾]。

Japanese Journal of Allergology Pub Date : 2024-01-01 DOI: 10.15036/arerugi.73.260

Tetsuhiro Sakihara

引用次数: 0

[TWO CASES OF LARYNGEAL EDEMA CAUSED BY SUBLINGUAL ALLERGEN IMMUNOTHERAPY]. [舌下过敏原免疫疗法导致喉头水肿的两个病例]。

Japanese Journal of Allergology Pub Date : 2024-01-01 DOI: 10.15036/arerugi.73.196

Yuki Maruyama, Kojiro Hirano, Eriko Sekino, Sawa Kamimura, Youichirou Narikawa, Isao Suzaki, Toshikazu Shimane

{"title":"[TWO CASES OF LARYNGEAL EDEMA CAUSED BY SUBLINGUAL ALLERGEN IMMUNOTHERAPY].","authors":"Yuki Maruyama, Kojiro Hirano, Eriko Sekino, Sawa Kamimura, Youichirou Narikawa, Isao Suzaki, Toshikazu Shimane","doi":"10.15036/arerugi.73.196","DOIUrl":"10.15036/arerugi.73.196","url":null,"abstract":"Sublingual immunotherapy is a widely used treatment, and serious adverse reactions such as anaphylaxis are rare. We report two cases of laryngeal edema as adverse reactions to sublingual immunotherapy, which could be continued due to a change in the administration method. Case 1 presents a 15-year-old male suspected to have had anaphylaxis due to the dust at the age of 6 years. He started treatment with Miticure® and developed laryngeal edema 30 minutes after taking the 10000JAU dose on the 10th day. laryngeal edema was treated with intravenous infusion. Case 2 presents a 48-year-old woman. She started treatment with Cidacure® and developed respiratory distress and laryngeal edema 1 hour after taking the 5000JAU dose on the 5th day. she had resolved mildly without therapeutic intervention. In both cases, the patients were switched to sublingual spitting, resumed with the initial dose cautiously, and were able to continue. Sublingual immunotherapy is a safe treatment, but sudden adverse reactions may occur. Laryngeal symptoms may be treated by changing to the sublingual spitting method, but laryngeal findings should be examined, and the dosage should be carefully increased.","PeriodicalId":35521,"journal":{"name":"Japanese Journal of Allergology","volume":"73 2","pages":"196-200"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140207758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[MAST CELLS, BASOPHILS AND ALLERGY]. [肥大细胞、嗜碱性粒细胞和过敏]。

Japanese Journal of Allergology Pub Date : 2024-01-01 DOI: 10.15036/arerugi.73.6

Yoshimichi Okayama

引用次数: 0

[THE EFFICACY OF BRONCHIAL THERMOPLASTY IN LONG-TERM MAINTENANCE OF ADULT PATIENTS WITH MODERATE TO SEVERE ASTHMA]. [支气管热成形术对中重度哮喘成年患者的长期疗效]。

Japanese Journal of Allergology Pub Date : 2024-01-01 DOI: 10.15036/arerugi.73.40

Takahiro Matsuyama, Jun Tanaka, Kazuya Tone, Kaoruko Shimizu, Takako Nakano, Koichiro Takahashi

{"title":"[THE EFFICACY OF BRONCHIAL THERMOPLASTY IN LONG-TERM MAINTENANCE OF ADULT PATIENTS WITH MODERATE TO SEVERE ASTHMA].","authors":"Takahiro Matsuyama, Jun Tanaka, Kazuya Tone, Kaoruko Shimizu, Takako Nakano, Koichiro Takahashi","doi":"10.15036/arerugi.73.40","DOIUrl":"https://doi.org/10.15036/arerugi.73.40","url":null,"abstract":"Background and aims: Bronchial thermoplasty (BT) is a bronchoscopic treatment for adult patients with moderate to severe asthma. A systematic review was conducted to examine the efficacy of this treatment.Methods: Randomized controlled comparing BT to a control in adult patients with moderate to severe asthma were added to the previously conducted systematic review. Literature published prior to July 2022 was selected.Results: Four trials were included in this study. BT resulted in significant improvement in quality of life. However, no significant difference in asthma control was observed. Moreover, the incidence of severe adverse events during the treatment period was increased by BT. Furthermore, BT did not improve lung function, increase withdrawal from oral corticosteroids, reduce frequency of rescue medication usage, or increase the number of symptom-free days.Conclusion: From a risk-benefit perspective, there is insufficient evidence to support a recommendation of BT in adult patients with moderate to severe asthma.","PeriodicalId":35521,"journal":{"name":"Japanese Journal of Allergology","volume":"73 1","pages":"40-51"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139973828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[BRONCHOPULMONARY ASPERGILLOSIS WITH COMORBID GRANULOMATOUS POLYANGIITIS IN A PATIENT WHO PRESENTED WITH EXOPHTHALMOS: A CASE REPORT]. [支气管肺曲霉病合并肉芽肿性多血管炎：病例报告]。

Japanese Journal of Allergology Pub Date : 2024-01-01 DOI: 10.15036/arerugi.73.1000

Akari Kodama, Tomoko Tajiri, Toru Yamabe, Yuki Furukawa, Yutaka Ito, Keima Ito, Yuta Mori, Kensuke Fukumitsu, Satoshi Fukuda, Yoshihiro Kanemitsu, Takehiro Uemura, Masaya Takemura, Tetsuya Oguri, Taio Naniwa, Akio Niimi

{"title":"[BRONCHOPULMONARY ASPERGILLOSIS WITH COMORBID GRANULOMATOUS POLYANGIITIS IN A PATIENT WHO PRESENTED WITH EXOPHTHALMOS: A CASE REPORT].","authors":"Akari Kodama, Tomoko Tajiri, Toru Yamabe, Yuki Furukawa, Yutaka Ito, Keima Ito, Yuta Mori, Kensuke Fukumitsu, Satoshi Fukuda, Yoshihiro Kanemitsu, Takehiro Uemura, Masaya Takemura, Tetsuya Oguri, Taio Naniwa, Akio Niimi","doi":"10.15036/arerugi.73.1000","DOIUrl":"https://doi.org/10.15036/arerugi.73.1000","url":null,"abstract":"There have been no reports of the coexistence of allergic bronchopulmonary aspergillosis (ABPA) and granulomatosis with polyangiitis (GPA). The first case of ABPA with comorbid GPA that developed exophthalmos is reported. A 69-year-old man was referred to our hospital for exophthalmos, fever, anorexia and weight loss. The patient had been diagnosed with ABPA six years earlier, which had been repeatedly treated but recurred with oral corticosteroids with or without antifungal therapy. The laboratory data on referral showed elevations of the white blood cell count, C-reactive protein and specific immunoglobulin E against Aspergillus fumigatus, but antineutrophil cytoplasmic antibody was not positive. Urinalysis showed proteinuria. Paranasal sinus and chest computed tomography showed sinusitis with osteochondral destruction, bronchiectasis, mucus plugging, and a pulmonary nodule. Orbital magnetic resonance imaging showed swelling of the medial rectus muscle and peripheral mass. The intraorbital tissue biopsy showed a necrotic granuloma and necrotizing vasculitis. The patient was diagnosed with GPA, on the basis of the Ministry of Health, Labour and Welfare's criteria of Japan. The patient was treated with induction therapy consisting of glucocorticoids and rituximab, and his symptoms improved. Though the pathogenesis common to ABPA and GPA remains unknown, neutrophilic inflammation induced by airway Aspergillus persistent infection might be involved. Study of further cases is needed.","PeriodicalId":35521,"journal":{"name":"Japanese Journal of Allergology","volume":"73 8","pages":"1000-1005"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142297190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Japanese Journal of Allergology Pub Date : 2024-01-01 DOI: 10.15036/arerugi.73.295

引用次数: 0

Japanese Journal of Allergology Pub Date : 2024-01-01 DOI: 10.15036/arerugi.73.871

引用次数: 0

[IS INHALED CORTICOSTEROID STEP-DOWN RECOMMENDED FOR ADULT ASTHMA PATIENTS HAVE BEEN WELL CONTROLLED OVER THE LONG TERM WITH MODERATE OR HIGH-DOSE INHALED CORTICOSTEROIDS?] [成年哮喘患者长期使用中等或大剂量吸入皮质类固醇后病情得到良好控制，是否建议减量使用吸入皮质类固醇？］

Japanese Journal of Allergology Pub Date : 2024-01-01 DOI: 10.15036/arerugi.73.206

Naoki Okada, Hiroki Kabata, Yoshihito Tanaka, Tetsuya Homma, Sunao Mikura

引用次数: 0